Contents
Download PDF
pdf Download XML
325 Views
125 Downloads
Share this article
Research Article | Volume 13 Issue:2 (, 2023) | Pages 94 - 99
Serum Uric Acid Levels As A Prognostic Marker in Acute Mi – A Cross Sectional Study
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
April 8, 2023
Abstract

Background: Cardiovascular diseases are one of the main causes of death in the world; among them is Ischemic Cardiac Disease.  Objective: To determine the role of serum uric acid levels in predicting in hospital outcome in Acute MI.  Methods: This observational cross sectional study was conducted in tertiary care hospital in Central India. The study was conducted from Nov 2020 to October 2022. Results: Majority of patients, 79.5% had ≥40 LVEF & rest 20.5% had <40 LVEF. Mean uric acid was significantly higher in Anterior Wall MI. Out of a total of 6 dead MI patients all come under the class IV KILLIP classification with significantly raised serum uric acid on days 0,3 & 5. The mean uric acid was significantly higher in KILLIP class IV on days 0,3 & 5. Conclusions: Serum UA can be used as a marker of short-term mortality in acute MI. Serum uric acid along with Killip’s classification should be considered for risk stratification in patients with AMI

Keywords
Recommended Articles
Research Article
A retrospective study of prevalence of deaths due to Poisoning in a tertiary care Hospital
...
Published: 26/08/2024
Download PDF
Research Article
Clinico-Hematological Profile of Anaemia Among Paediatric Patients: A Hospital-Based Study
Published: 23/03/2022
Download PDF
Research Article
Study of Clinical Profile of Primary Headache Disorders and Its Effect on Quality of Life
...
Published: 15/09/2025
Download PDF
Research Article
Comparison of Conventional Dose of Bupivacaine and Low-Dose Bupivacaine-Fentanyl Spinal Anaesthesia in Maintaining Hemodynamic Stability in Patients Undergoing Transurethral Resection of Prostate
Published: 10/06/2022
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.